Bruno Mougin Selected Research

Hormones (Hormone)

8/2006

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruno Mougin Research Topics

Disease

7	Septic Shock (Toxic Shock Syndrome) 12/2011 - 01/2005
6	Breast Neoplasms (Breast Cancer) 03/2011 - 09/2004
6	Rheumatoid Arthritis 01/2011 - 07/2006
5	Sepsis (Septicemia) 01/2010 - 01/2005
3	Shock 10/2010 - 01/2005
2	Neoplasms (Cancer) 09/2007 - 01/2006
2	Necrosis 07/2007 - 02/2007
1	Infections 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2011
1	Breast Diseases (Breast Disease) 12/2010
1	Osteoarthritis 04/2010
1	Inflammation (Inflammations) 04/2010
1	Arthritis (Polyarthritis) 12/2007
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2007
1	Uveitis 07/2007
1	Neoplasm Metastasis (Metastasis) 08/2006
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2006
1	Disease Susceptibility (Diathesis) 04/2006

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 12/2011 - 09/2004
4	Biomarkers (Surrogate Marker)IBA 12/2011 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 04/2010 - 01/2005
3	HLA-DR Antigens (HLA-DR)IBA 01/2010 - 01/2005
3	EnzymesIBA 09/2007 - 02/2007
3	CytokinesIBA 07/2007 - 01/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2011 - 01/2005
2	EpitopesIBA 12/2007 - 02/2007
2	DNA (Deoxyribonucleic Acid)IBA 12/2007 - 01/2006
2	Infliximab (Remicade)FDA Link 11/2007 - 07/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2007 - 07/2007
2	Plasminogen Activator Inhibitor 1IBA 09/2007 - 08/2006
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 09/2007 - 08/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 09/2007 - 08/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2006 - 01/2005
2	Interleukin-10 (Interleukin 10)IBA 04/2006 - 01/2005
2	Estrogen Receptor alphaIBA 01/2006 - 09/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2006 - 09/2004
1	Estrogen ReceptorsIBA 03/2011
1	Interferon Type IIBA 01/2011
1	Caspase 3 (Caspase-3)IBA 01/2010
1	Annexin A5IBA 01/2010
1	Enterotoxins (Enterotoxin)IBA 09/2009
1	Staphylococcal enterotoxin AIBA 09/2009
1	LigandsIBA 05/2008
1	CX3C Chemokine Receptor 1IBA 05/2008
1	Chemokine CX3CL1IBA 05/2008
1	Plasminogen InactivatorsIBA 09/2007
1	Nucleic AcidsIBA 09/2007
1	ImmunosorbentsIBA 09/2007
1	Rheumatoid FactorIBA 07/2007
1	Tumor Necrosis Factor InhibitorsIBA 07/2007
1	Interleukin-1 (Interleukin 1)IBA 07/2007
1	Genetic Markers (Genetic Marker)IBA 02/2007
1	InterleukinsIBA 02/2007
1	Hormones (Hormone)IBA 08/2006
1	PlasminogenIBA 08/2006
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 07/2006
1	ErbB Receptors (EGF Receptor)IBA 01/2006
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2005
1	Peptides (Polypeptides)IBA 01/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2005
1	HMGB1 Protein (HMG1)IBA 01/2005
1	Transcription Factors (Transcription Factor)IBA 01/2005
1	cyclophilin BIBA 09/2004

Therapy/Procedure

3	Therapeutics 12/2011 - 10/2010
1	Neoadjuvant Therapy 03/2011
1	Precision Medicine 01/2011